Yuichi Iwaki insider trades: Medicinova (MNOV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yuichi reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2020 | MNOV | ↑ Buy | 20,000 | $3.10 | $62K | Direct | Mar 12, 2020 (0d) |
| Feb 2, 2009 | MNOV | ↑ Buy | 1,800 | $2.25 | $4K | Indirect | Feb 4, 2009 (2d) |
| Jan 27, 2009 | MNOV | ↑ Buy | 1,200 | $2.19 | $3K | Indirect | Jan 27, 2009 (0d) |
| Jan 26, 2009 | MNOV | ↑ Buy | 1,650 | $2.15 | $4K | Indirect | Jan 27, 2009 (1d) |
| Jan 23, 2009 | MNOV | ↑ Buy | 2,200 | $2.15 | $5K | Direct | Jan 27, 2009 (4d) |
| Jan 20, 2009 | MNOV | ↑ Buy | 3,271 | $2.03 | $7K | Direct | Jan 21, 2009 (1d) |
| Jan 15, 2009 | MNOV | ↑ Buy | 6,000 | $1.59 | $10K | Direct | Jan 15, 2009 (0d) |
| May 5, 2008 | AVGN | ↓ Sell | 5,643 | $3.22 | $18K | Sole owner, Metic Transplantation Lab In | May 6, 2008 (1d) |
| Oct 4, 2007 | MNOV | ↑ Buy | 1,300 | $8.21 | $11K | Indirect | Oct 4, 2007 (0d) |
| Oct 3, 2007 | MNOV | ↑ Buy | 8,700 | $8.08 | $70K | Indirect | Oct 3, 2007 (0d) |
| Nov 28, 2006 | AVGN | ↓ Sell | 20,000 | $5.93 | $119K | General Partner, Iwaki Family Limited Pa | Nov 28, 2006 (0d) |
| Mar 10, 2006 | AVGN | ↓ Sell | 80,000 | $5.59 | $447K | General Partner, Iwaki Family Limited Pa | Mar 10, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MNOV insiders
Open-market trades in the last 12 months
About Yuichi Iwaki's insider trades
Yuichi Iwaki is President and CEO at Medicinova (MNOV). Since Mar 10, 2006, Yuichi has reported 9 open-market purchases worth $174K and 3 sales worth $584K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (28 filings), option exercises (11 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNOV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.